Advertisement
Organisation › Details
Roivant (Group)
Roivant is a commercial-stage biopharmaceutical company that aims to improve the lives of patients by accelerating the development and commercialization of medicines that matter. In addition to VTAMA, Roivant’s pipeline includes IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting the neonatal Fc receptor (“FcRn”) in development across several IgG-mediated autoimmune indications, and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 for the treatment of dermatomyositis and non-infectious uveitis, in addition to other clinical stage molecules. We advance our pipeline by creating nimble subsidiaries or “Vants” to develop and commercialize our medicines and technologies. Beyond therapeutics, Roivant also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. *
Start | 2017-08-11 existent | |
Industry | BIOTECH | |
Person | Gline, Matthew (Matt) (Roivant 202102 CEO of Roivant Sciences) | |
Street | 50 Broadway 7th Floor | |
City | SW1H 0DB London | |
Tel | +44-207-400-3347 | |
Address record changed: 2024-09-24 | ||
Basic data | Employees | E: 501 to 1,000 (2024-03-31) |
Currency | USD | |
Annual sales | 124,795,000 (revenue, net, consolidated (2023/24) 2024-03-31) | |
Profit | 4,231,206,000 (2024-03-31) | |
Cash | 6,535,706,000 (2024-03-31) | |
* Document for »About Section«: Organon & Co.. (9/18/24). "Press Release: Organon to Acquire Dermavant including Its Innovative Dermatologic Therapy, Vtama (tapinarof) Cream, 1%". Jersey City, NJ. | ||
Record changed: 2024-09-28 |
Advertisement
More documents for Roivant (Group)
- [1] Organon & Co.. (9/18/24). "Press Release: Organon to Acquire Dermavant including Its Innovative Dermatologic Therapy, Vtama (tapinarof) Cream, 1%". Jersey City, NJ....
- [2] Roivant Sciences GmbH. (9/10/24). "Press Release: Roivant Unveils New Pipeline Program Mosliciguat, a Potential First-In-Class and Best-In-Category Inhaled Once-Daily Soluble Guanylate Cyclase (sGC) Activator". Basel, London & New York, NY....
- [3] VantAI. (2/13/24). "Press Release: VantAI Enters Collaboration With Bristol Myers Squibb to Accelerate Molecular Glue Drug Discovery Through Artificial Intelligence". New York, NY....
- [4] VantAI. (2/7/24). "Press Release: VantAI Appoints Jae Won Kim as Chief Operating Officer and Chief Financial Officer". New York, NY....
- [5] Roche. (10/23/23). "Press Release: Roche Enters into a Definitive Agreement to Acquire Telavant". Basel....
- [6] VantAI. (4/20/22). "Press Release: VantAI Forms Research Collaboration with Boehringer Ingelheim to Identify Novel Protein Degraders". new York, NY & Ingelheim....
- [7] Affimed N.V.. (3/31/22). "Press Release: Affimed Reports 2021 Financial Results and Highlights Recent Operational Progress". Heidelberg....
- [8] Roivant Sciences GmbH. (2/26/21). "Press Release: Roivant Grows Computational Drug Discovery Engine with Acquisition of Silicon Therapeutics". New York, NY, Boston, MA & Basel....
- [9] Medigene AG. (11/12/20). "Press Release: Medigene Provides Q3 2020 Update". Planegg-Martinsried....
- [10] Medigene AG. (10/19/20). "Press Release: Medigene and Cytovant Enter into Service Agreement for DC Vaccine Manufacturing Process Development". Planegg-Martinsried....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top